Do you start a statin for cardioprotection in a patient with no lipid indication who is beginning anthracycline chemotherapy?

My answer is that this is a nuanced and shared decision making discussion.

First, patient starting new chemo needs pre cancer cardiotoxicity risk assessment using the HFA-ICOS risk calculator https://www.cancercalc.com/hfa-icos_cardio_oncology_risk_assessment.php.

Next the patient needs optimization o...